David Liew
The University of Melbourne(AU)Austin Health(AU)
Publications by Year
Research Areas
Vasculitis and related conditions, Rheumatoid Arthritis Research and Therapies, Coagulation, Bradykinin, Polyphosphates, and Angioedema, Cancer Immunotherapy and Biomarkers, SARS-CoV-2 and COVID-19 Research
Most-Cited Works
- → Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry(2020)1,173 cited
- → A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19(2020)216 cited
- → Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey(2021)169 cited
- → COVID-19 therapeutics: Challenges and directions for the future(2022)164 cited
- → The Potential for Repurposing Anti-TNF as a Therapy for the Treatment of COVID-19(2020)129 cited
- → Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular Disease(2021)117 cited
- → Rheumatic immune-related adverse events secondary to anti–programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case series(2018)91 cited
- → Waiting for JAK inhibitor safety data(2022)85 cited
- → Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19(2020)83 cited
- → Cardiovascular morbidity and mortality in ankylosing spondylitis and psoriatic arthritis(2018)79 cited